CTORCitius Oncology, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 13889
Ticker: CTOR
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2024-08-13
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: CTOR

Detail

Enriched 2026-08-14 20:47

Market cap: $75,454,247.05
Shares outstanding (class): 92,981,204
Shares outstanding (weighted): 92,981,204
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: —
Location: CRANFORD, NJ
Homepage: https://www.citiusonc.com
Description: Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.

Market cap and share counts drift.

Funds holding this security

4 funds · 4 positions · $361.1K reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$229.4K	0.00%	370,100 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$102.1K	0.00%	164,724 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$28.1K	0.00%	45,261 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$1.5K	0.00%	2,491 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERCTOR
FIGI_COMPOSITEBBG01163HKY3
FIGI_SHARE_CLASSBBG01163HLS8
CIK0001851484
ISINUS17331Y1091
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a pharmaceutical preparations company per SIC 2834.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.